Accession Number: | 0001593968-21-002050 |
Date: | 2021-09-01 |
Issuer: | KARUNA THERAPEUTICS, INC. (KRTX) |
Original Submission Date: |
PANDE ATUL
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON, MA 02110
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-01 | M | 2,500 | a | $16.00 | 2,500 | direct | ||
COMMON STOCK | 2021-09-01 | S | 2,500 | d | $117.82 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 16.0 | 2021-09-01 | deemed execution date | M | 2,500 (d) | 2020-06-15 | 2029-06-26 | common stock 2,500 | $16.00 | 12,500 | direct |
ID | footnote |
---|---|
f1 | the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 1, 2021. |